Leukemia Research
Volume 28, Issue 3 , Pages 301-306 , March 2004

Inhibitory effects of phaseolotoxin on proliferation of leukemia cells HL-60, K-562 and L1210 and pancreatic cells RIN-m5F

  • André S Bachmann

      Affiliations

    • Corresponding Author InformationCorresponding author. Present address: Cancer Research Center of Hawaii, University of Hawaii at Manoa, 1236 Lauhala Street, Honolulu, HI 96813, USA. Tel.: +1-808-586-2962; fax: +1-808-586-2970.
  • ,
  • Ronghui Xu

      Affiliations

    • Present address: Department of Zoology, University of Hawaii at Manoa, Honolulu, HI, USA.
  • ,
  • Lal Ratnapala
  • ,
  • Suresh S Patil

Received 21 April 2003 ,Accepted 26 July 2003.

References 

  1. Mitchell RE, Bieleski R. Involvement of phaseolotoxin in halo blight of beans transport and conversion to functional toxin. Plant Physiol. 1977;60:723
  2. Mitchell RE. Bean halo-blight toxin. Nature UK. 1976;260:75
  3. Bender CL, Alarcon-Chaidez F, Gross DC. Pseudomonas syringae phytotoxins: mode of action, regulation, and biosynthesis by peptide and polyketide synthetases. Microbiol Mol Biol Rev. 1999;63:266
  4. Patil SS, Tam LQ, Sakai WS. Mode of action of the toxin from Pseudomonas phaseolicola. Part I. Toxin specificity, chlorosis, and ornithine accumulation. Plant Physiol. 1972;49:803
  5. Tam LQ, Patil SS. Mode of action of the toxin from Pseudomonas phaseolicola. Part II. Mechanism of inhibition of bean ornithine carbamoyltransferase. Plant Physiol. 1972;49:808
  6. Patil SS, Kolattukudy PE, Dimond AE. Inhibition of ornithine carbamyl transferase from bean plants by toxin of Pseudomonas phaseolicola. Plant Physiol. 1970;46:752
  7. Kwok OC, Ako H, Patil SS. Inactivation of bean ornithine carbamoyltransferase by phaseolotoxin: effect of phosphate. Biochem Biophys Res Commun. 1979;89:1361
  8. Moore RE, Niemczura WP, Kwok OCH, Patil SS. Inhibitors of ornithine carbamoyltransferase from Pseudomonas syringae pv. phaseolicola. Revised structure of phaseolotoxin. Tetrahedron Lett. 1984;25:3931
  9. Langley DB, Templeton MD, Fields BA, Mitchell RE, Collyer CA. Mechanism of inactivation of ornithine transcarbamoylase by Nδ-(N′-sulfodiaminophosphinyl)-l-ornithine, a true transition state analogue? Crystal structure and implications for catalytic mechanism. J Biol Chem. 2000;275:20012
  10. Bachmann AS, Matile P, Slusarenko AJ. Inhibition of ornithine decarboxylase activity by phaseolotoxin: implications for symptom production in halo blight of French bean. Physiol Mol Plant Pathol. 1998;53:287
  11. Tabor CW, Tabor H. Polyamines. Annu Rev Biochem. 1984;53:749
  12. Pegg AE. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J. 1986;234:249
  13. Heby O, Persson L. Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci. 1990;15:153
  14. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res. 1988;48:759
  15. Pegg AE, McCann PP. S-Adenosylmethionine decarboxylase as an enzyme target for therapy. Pharmacol Ther. 1992;56(3):359
  16. Levin VA, Uhm JH, Jaeckle KA, Choucair A, Flynn PJ, Yung WKA, et al.  Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiform. Clin Cancer Res. 2000;6:3878
  17. Davidson NE, Hahm HA, McCloskey DE, Woster PM, Casero RA. Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endocr Relat Cancer. 1999;6:69
  18. Takahashi Y, Mai M, Nishioka K. alpha-Difluoromethylornithine induces apoptosis as well as anti-angiogenesis in the inhibition of tumor growth and metastasis in a human gastric cancer model. Int J Cancer. 2000;85:243
  19. Meyskens FL, Gerner EW. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res. 1999;5(5):945
  20. McCann PP, Pegg AE. Ornithine decarboxylase as an enzyme target for therapy. Pharmacol Ther. 1992;54:195
  21. Staskawicz BJ, Panopoulos NJ. A rapid and sensitive microbiological assay for phaseolotoxin. Phytopathology. 1979;69:663
  22. Sambrook J, Fritsch EF, Maniatis T. In: Nolan C, editor. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
  23. Koeffler HP. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood. 1983;62:709
  24. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975;45(3):321
  25. Bachmann AS, Surovoy A, Jung G, Moelling K. Integrin receptor-targeted transfer peptides for efficient delivery of antisense oligodeoxynucleotides. J Mol Med. 1998;76:126
  26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem. 1976;72:248
  27. Luk GD, Civin CI, Weissmann RM, Baylin SB. Ornithine decarboxylase: essential in proliferation but not differentiation of human promyelocytic leukemia cells. Science. 1982;216:75
  28. Derry WB, Wilson L, Khan IA, Luduena RF, Jordan MA. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes. Biochemistry. 1997;36:3554
  29. Mullins DW, Alleva DG, Burger CJ, Elgert KD. Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production. Immunopharmacology. 1997;37:63
  30. Auvinen M, Paasinen A, Andersson LC, Holtta E. Ornithine decarboxylase activity is critical for cell transformation. Nature. 1992;360:355
  31. Bachmann AS, Matile Ph, Patil SS, Slusarenko AJ. Phaseolotoxin: a possible new inhibitor of ornithine decarboxylase. In: Proceedings of the Tokyo International Symposium on Polyamines; 1996 [abstract P40, p. 162–163].

PII: S0145-2126(03)00267-4

doi: 10.1016/j.leukres.2003.07.002

Leukemia Research
Volume 28, Issue 3 , Pages 301-306 , March 2004